Covance Supports Fight Against Juvenile Diabetes
Covance’s Madison location “Fills the Boulevard with Sneakers” to support an employee’s Ride to Cure Diabetes
Research regarding juvenile diabetes is near and dear to Jeff, a Covance Madison employee - his 15 year old twins have juvenile diabetes. Though they have managed to do things other children do through blood sugar management and the education of all who touch their lives, they look to the future for a cure.
Jeff writes on his own webpage, “Over the years, we have participated in the Walk to Cure Diabetes and estimate that we have raised $5,000. This year, we are taking a different approach. I am signed up for the Ride to Cure Diabetes which is a 100 mile ride in LaCrosse, Wisconsin on August 19.
“I am riding with an amazing bunch of experienced riders who all support Diabetes. And to top things off, Covance, my employer, is backing me on the ride. They will help me fundraise and are very committed to bringing the miracles of modern medicine to everyone. Thank you, Covance!”
In support of Jeff’s Ride for the Cure, Covance Madison employees will aim to fill its large, walking thoroughfare – referred to as the “Boulevard” - with paper sneakers. Employees will make a donation to receive a paper sneaker, with all proceeds going to the Juvenile Diabetes Research Foundation (JDRF). Covance will also offer prize drawings for those who donate.
Click here to learn more about this Ride to Cure Diabetes or to make a donation.
www.jdrf.org -- “JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is now the largest charitable supporter of T1D research. The goal of JDRF research is to improve the lives of all people affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal.
“ Since its founding in 1970, JDRF has awarded more than $1.6 billion to diabetes research. Past JDRF efforts have helped to significantly advance the care of people with this disease, and have expanded the critical scientific understanding of T1D. JDRF will not rest until T1D is fully conquered. More than 80 percent of JDRF's expenditures directly support research and research-related education.”
There's a glimmer of hope seen in a new optimism among employers